Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alen, M. |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F. |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A.H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y.A. |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P. |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J. |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S. |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T. |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Rämet, M(ika) |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ruskoaho, H. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Tjäderhane, L. |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R. |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds
|
| | Narrow-band ultraviolet B (NB UV-B) exposures improve mood in healthy individuals differently depending on chronotype. | Vuolteenaho, O. | 298 days | save |  |  |  | |
| Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up. | Vuolteenaho, O. | 1031 days | save | | | | |
| Isolation of new ligands for orphan receptor MRGPRX1-hemorphins LVV-H7 and VV-H7. | Vuolteenaho, O. | 1038 days | save | | | | |
| Systemic Hypoxia Increases Circulating Concentration of Apelin in Humans. | Vuolteenaho, O. | 1048 days | save | | | | |
| Mast cell degranulation via MRGPRX2 by isolated human albumin fragments. | Vuolteenaho, O. | 1049 days | save | | | | |
| Cytokine data obtained from synovial stromal cells of patients with rheumatoid arthritis or osteoarthritis. | Vuolteenaho, O. | 1144 days | save | | | | |
| Niche matters: The comparison between bone marrow stem cells and endometrial stem cells and stromal fibroblasts reveal distinct migration and cytokine profiles in response to inflammatory stimulus. | Vuolteenaho, O. | 1181 days | save | | | | |
| Gestational hyperglycemia reprograms cardiac gene expression in rat offspring. | Vuolteenaho, O. | 1217 days | save | | | | |
| Inhibition of Atrial Wall Stretch-Induced Cardiac Hormone Secretion by Lavendustin A, a Potent Tyrosine Kinase Inhibitor1. | Vuolteenaho, O. | 1241 days | save | | | | |
| Factors Derived from Adrenals Are Required for Activation of Cardiac Gene Expression in Angiotensin II-Induced Hypertension. | Vuolteenaho, O. | 1241 days | save | | | | |
| Gene Structure of a New Cardiac Peptide Hormone: A Model for Heart-Specific Gene Expression1. | Vuolteenaho, O. | 1241 days | save | | | | |
| A Novel Cardiac Hormone Related to A-, B-, and C-Type Natriuretic Peptides. | Vuolteenaho, O. | 1241 days | save | | | | |
| Atrial Natriuretic Peptide (ANP) Inhibits Its Own Secretion via ANPA Receptors: Altered Effect in Experimental Hypertension. | Vuolteenaho, O. | 1241 days | save | | | | |
| Adrenomedullin Gene Expression in the Rat Heart is Stimulated by Acute Pressure Overload: Blunted Effect in Experimental Hypertension. | Vuolteenaho, O. | 1241 days | save | | | | |
| 1,25(OH)2D3 and calcipotriol, its hypocalcemic analog, exert a long-lasting anti-inflammatory and anti-proliferative effect in synoviocytes cultured from patients with rheumatoid arthritis and osteoarthritis. | Vuolteenaho, O. | 1250 days | save | | | | |
| Effect of Hypoxemia with or without Increased Placental Vascular Resistance on Fetal Left and Right Ventricular Myocardial Performance Index in Chronically Instrumented Sheep. | Vuolteenaho, O. | 1421 days | save | | | | |
| Placental structural abnormalities have detrimental hemodynamic consequences in a rat model of maternal hyperglycemia. | Vuolteenaho, O. | 1442 days | save | | | | |
| Neoplastic extracellular matrix environment promotes cancer invasion in vitro. | Vuolteenaho, O. | 1544 days | save | | | | |
| Bone Marrow Mononuclear Cell Transplantation Restores Inflammatory Balance of Cytokines after ST Segment Elevation Myocardial Infarction. | Vuolteenaho, O. | 1663 days | save | | | | |
| Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart. | Vuolteenaho, O. | 1688 days | save | | | | |
| Prognostic value of N-terminal natriuretic peptides in systemic sclerosis: a single centre study. | Vuolteenaho, O. | 2076 days | save | | | | |
| Bone morphogenetic protein-2 - a potential autocrine/paracrine factor in mediating the stretch activated b-type and atrial natriuretic peptide expression in cardiac myocytes. | Vuolteenaho, O. | 2128 days | save | | | | |
| Circulating N-terminal brain natriuretic peptide and cardiac function in response to acute systemic hypoxia in healthy humans. | Vuolteenaho, O. | 2199 days | save | | | | |
| Connective Tissue Growth Factor Inhibition Attenuates Left Ventricular Remodeling and Dysfunction in Pressure Overload-Induced Heart Failure. | Vuolteenaho, O. | 2294 days | save | | | | |
| Depressive symptoms and cardiovascular burden related mortality among the aged. | Vuolteenaho, O. | 2313 days | save | | | | |
| Plasma B-type natriuretic peptide (BNP) in acute Puumala hantavirus infection. | Vuolteenaho, O. | 2378 days | save | | | | |
| Endothelin-1 signalling controls early embryonic heart rate in vitro and in vivo. | Vuolteenaho, O. | 2405 days | save | | | | |
| B-type natriuretic peptide and severity of cognitive disorder. | Vuolteenaho, O. | 2468 days | save | | | | |
| Hypoxia-Inducible Factor 1-induced G protein-coupled receptor 35 expression is an early marker of progressive cardiac remodeling. | Vuolteenaho, O. | 2470 days | save | | | | |
| Maternal hyperglycemia leads to fetal cardiac hyperplasia and dysfunction in a rat model. | Vuolteenaho, O. | 2559 days | save | | | | |
| Hypoxia increases the release of salmon cardiac peptide (sCP) from the heart of rainbow trout (Oncorhynchus mykiss) under constant mechanical load in vitro. | Vuolteenaho, O. | 2567 days | save | | | | |
| Intermittent levosimendan treatment in patients with severe congestive heart failure. | Vuolteenaho, O. | 2673 days | save | | | | |
| Neurogenic Pulmonary Edema in Patients with Nontraumatic Intracerebral Hemorrhage: Predictors and Association with Outcome. | Vuolteenaho, O. | 2697 days | save | | | | |
| The prognostic capacity of B-type natriuretic peptide on cognitive disorder varies by age. | Vuolteenaho, O. | 2953 days | save | | | | |
| Tezosentan inhibits uptake of proinflammatory endothelin-1 in stenotic aortic valves. | Vuolteenaho, O. | 3019 days | save | | | | |
| Localization of natriuretic peptides in the cardiac pacemaker of Atlantic salmon (Salmo salar L.). | Vuolteenaho, O. | 3050 days | save | | | | |
| Myocardial Performance and its Acute Response to Angiotensin II Infusion in Fetal Sheep Adapted to Chronic Anemia. | Vuolteenaho, O. | 3173 days | save | | | | |
| Intramyocardial BNP Gene Delivery Improves Cardiac Function Through Distinct Context-Dependent Mechanisms. | Vuolteenaho, O. | 3350 days | save | | | | |
| Natriuretic peptides and collagen biomarkers in patients with medical treatment for hypertension. | Vuolteenaho, O. | 3392 days | save | | | | |
| Inverted mitral inflow pattern in echocardiography among the elderly - A marker of non-cardiovascular mortality and cognitive dysfunction. | Vuolteenaho, O. | 3411 days | save | | | | |
| N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension. | Vuolteenaho, O. | 3461 days | save | | | | |
| Key roles of endothelin-1 and p38 MAPK in the regulation of atrial stretch response. | Vuolteenaho, O. | 3524 days | save | | | | |
| Mini-Mental State Examination score and B-type natriuretic peptide as predictors of cardiovascular and total mortality in an elderly general population. | Vuolteenaho, O. | 3552 days | save | | | | |
| Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction. | Vuolteenaho, O. | 3555 days | save | | | | |
| Characterization of Molecular Forms of N-Terminal B-Type Natriuretic Peptide In Vitro. | Vuolteenaho, O. | 3562 days | save | | | | |
| Collagen XV Is Necessary for Modeling of the Extracellular Matrix and Its Deficiency Predisposes to Cardiomyopathy. | Vuolteenaho, O. | 3586 days | save | | | | |
| B-type natriuretic peptide as a predictor of declining cognitive function and dementia--a cohort study of an elderly general population with a 5-year follow-up. | Vuolteenaho, O. | 3743 days | save | | | | |
| Metoprolol Treatment Lowers Thrombospondin-4 Expression in Rats with Myocardial Infarction and Left Ventricular Hypertrophy. | Vuolteenaho, O. | 3756 days | save | | | | |
| Apelin and its receptor APJ in human aortic valve stenosis. | Vuolteenaho, O. | 3820 days | save | | | | |
| The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors. | Vuolteenaho, O. | 3833 days | save | | | | |
| | 
report | next » | | |
|
